Apolo V Acquisition Corp. Announces Shareholder Approvals

Executive Summary

• Apolo V Acquisition Corp. announced that shareholders approved all resolutions related to its proposed qualifying transaction with TelyRx, Inc., including a name change to “TelyRx Holdings Inc.” and share‑consolidation plans.
• The election of directors received 100% approval; the share‑capital reorganization was approved by 98.6% of votes.
• An omnibus equity incentive plan and appointment of RSM Canada LLP as auditors were also ratified, clearing key governance steps needed to complete the transaction.

Key Details

• Election of Directors: 100% shareholder approval.
• Name Change to “TelyRx Holdings Inc.” (or other name determined by TelyRx): 100% approval.
• Share Consolidation Ratio: Approved range of 1 post‑consolidation share for every 20–60 pre‑consolidation shares; received 100% approval.
• Share‑Capital Reorganization: Creation of “Subordinate Voting Shares” with special rights and a new class called “Proportionate Voting Shares”; approved by 98.6% of votes (meeting the TSXV majority‑of‑minority requirement).
• Omnibus Equity Incentive Plan: Approved by 98.6% of shareholders, to be adopted upon completion of the Qualifying Transaction.
• Auditor Appointment: RSM Canada LLP approved as post‑transaction auditors with 100% shareholder support.
• Overall Voting Outcome: All resolutions passed, meeting or exceeding TSXV and TSX majority‑of‑minority thresholds.

Notable Quotes

(No direct quotes were provided in the release.)